Codex Genetics is a pioneering brand in Asia that is revolutionizing healthcare management through the power of genomic sequencing. With their integrated CoGenesis® assays and platforms, they are accelerating diagnostic, treatment, and management processes, ultimately improving patient outcomes. Their extensive range of bioinformatics products and services includes hereditary cancer tests, neurodegenerative disease tests, drug response tests, pan-cancer marker tests, congenital cardiovascular disease assessments, metagenomics, and retinitis pigmentosa evaluations.

Codex Genetics is committed to delivering the highest standard of information security and accuracy. They have earned the ISO27001 certifications for their Information Security Management System, ensuring the consistent protection and safeguarding of personally identifiable information. Additionally, they have successfully passed the Genomics Quality Assessment scheme for Next Generation Sequencing, proving their industry-leading accuracy.

Codex Genetics' founding team consists of world-class scientists and engineers with extensive training from prestigious institutions. They are dedicated to pushing the boundaries of healthcare and democratizing access to genomic technologies across Asia. With their expertise and commitment, Codex Genetics is transforming healthcare for the better